Guardion Health Sciences Inc (GHSI)
8.62
-0.02
(-0.23%)
USD |
NASDAQ |
May 16, 16:00
8.66
+0.04
(+0.46%)
After-Hours: 20:00
Guardion Health Sciences Max Drawdown (5Y): 99.58% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.58% |
March 31, 2024 | 99.58% |
February 29, 2024 | 99.58% |
January 31, 2024 | 99.58% |
December 31, 2023 | 99.58% |
November 30, 2023 | 99.58% |
October 31, 2023 | 99.58% |
September 30, 2023 | 99.58% |
August 31, 2023 | 99.58% |
July 31, 2023 | 99.58% |
June 30, 2023 | 99.58% |
May 31, 2023 | 99.58% |
April 30, 2023 | 99.58% |
March 31, 2023 | 99.58% |
February 28, 2023 | 99.46% |
January 31, 2023 | 99.46% |
December 31, 2022 | 99.39% |
November 30, 2022 | 99.39% |
October 31, 2022 | 99.39% |
September 30, 2022 | 99.39% |
August 31, 2022 | 99.37% |
July 31, 2022 | 99.37% |
June 30, 2022 | 99.37% |
May 31, 2022 | 99.34% |
April 30, 2022 | 99.19% |
Date | Value |
---|---|
March 31, 2022 | 99.19% |
February 28, 2022 | 99.19% |
January 31, 2022 | 97.77% |
December 31, 2021 | 97.07% |
November 30, 2021 | 95.46% |
October 31, 2021 | 95.46% |
September 30, 2021 | 95.46% |
August 31, 2021 | 95.46% |
July 31, 2021 | 95.46% |
June 30, 2021 | 95.46% |
May 31, 2021 | 95.46% |
April 30, 2021 | 95.46% |
March 31, 2021 | 95.46% |
February 28, 2021 | 95.46% |
January 31, 2021 | 95.46% |
December 31, 2020 | 95.46% |
November 30, 2020 | 95.46% |
October 31, 2020 | 95.33% |
September 30, 2020 | 95.33% |
August 31, 2020 | 95.33% |
July 31, 2020 | 95.33% |
June 30, 2020 | 95.33% |
May 31, 2020 | 95.33% |
April 30, 2020 | 95.33% |
March 31, 2020 | 95.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.41%
Minimum
May 2019
99.58%
Maximum
Mar 2023
95.79%
Average
95.46%
Median
Nov 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |